menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  • ReachMD Healthcare Image
    Medical News

    Mobile Teams Bring COVID-19 Vaccines to Rural Villages in Sierra Leone

  • ReachMD Healthcare Image
    Medical News

    Changes After COVID-19: Science Academies Discuss Global Health Approaches for …

  • ReachMD Healthcare Image
    Medical News

    The Big Lesson from Past Pandemics? Avoid Panic Buying, Says New Research

Programs

  • Approaches to Individualizing Testosterone Replacement Therapy
    Clinician's Roundtable

    Approaches to Individualizing Testosterone Replacement Therapy

  • What’s New in Treating the Anticoagulated Patient with ICH?
    CME/CE Live Broadcast

    May 16, 2024

    13:15 - 14:45 CEST

    What’s New in Treating the Anticoagulated Patient with ICH?

  • Experts on the Ground: New Data and Practical Clinical Integration of Therapies…
    CME/CE

    Experts on the Ground: New Data and Practical Clinical Integration of Therapies Approved for IgAN

    1.00 credits
  • Preventive PCI versus optimal medical therapy only for vulnerable plaques
    ACC Action Center

    Preventive PCI versus optimal medical therapy only for vulnerable plaques

  • Overcoming Barriers to Timely Diagnosis and Classification of Interstitial Lung…
    CME/CE

    Overcoming Barriers to Timely Diagnosis and Classification of Interstitial Lung Disease: Considerations for Radiologists

    1.00 credits
  • Understanding CIAS: What Does Current Literature Say About the Etiology and Pat…
    MinuteCE®

    Understanding CIAS: What Does Current Literature Say About the Etiology and Pathophysiology of CIAS?

    1.00 program credits

Clinical Practice

  • Lessons in Locum Tenens: Key Insights from the Locumstory Physician Advisory Bo…
    Spotlight on Locum Tenens

    Lessons in Locum Tenens: Key Insights from the Locumstory Physician Advisory Board

  • ACC 2024: The PIONEER AF-PCI Trial
    NEW EPISODE
    MinuteCE®

    ACC 2024: The PIONEER AF-PCI Trial 

    0.50 program credits
  • Pulmonary Arterial Hypertension: Screening, Diagnosis, and Optimizing Management
    CME/CE

    Pulmonary Arterial Hypertension: Screening, Diagnosis, and Optimizing Management

    1.00 credits
  • Extended Dosing Intervals in Patients with Wet AMD and DME
    Medical Industry Feature

    Extended Dosing Intervals in Patients with Wet AMD and DME

  • The Gene Messenger: Advancing Neurological Gene Therapy
    Medical Industry Feature

    The Gene Messenger: Advancing Neurological Gene Therapy

  • Monitoring Treatment Reponses in CLL: A Review of Key Protocols
    Project Oncology®

    Monitoring Treatment Reponses in CLL: A Review of Key Protocols

Doctors Lounge

  • KOL Knockout™: Cancer Pain Management Edition
    CME/CE

    KOL Knockout™: Cancer Pain Management Edition

    1.50 credits
  • Poster Pearl: Imaging-Based Localization for MCED Tests Yields Lower Diagnostic…
    Project Oncology®

    Poster Pearl: Imaging-Based Localization for MCED Tests Yields Lower Diagnostic Burden

  • Poster Pearl: Improved Sensitivity of a Multi-Analyte Early Detection Test Base…
    Project Oncology®

    Poster Pearl: Improved Sensitivity of a Multi-Analyte Early Detection Test Based on Mutation, Methylation, Aneuploidy, & Protein Biomarkers

  • Op-Ed: The Growing Issue of Drug Shortages
    Op-Ed

    Op-Ed: The Growing Issue of Drug Shortages

  • Recognizing and Addressing Medical Gaslighting in Healthcare
    NeuroFrontiers

    Recognizing and Addressing Medical Gaslighting in Healthcare

  • Disparities in DMT Access: Women with MS Are Less Likely to Receive Treatment
    NeuroFrontiers

    Disparities in DMT Access: Women with MS Are Less Likely to Receive Treatment

CME

  • What Dermatologists & Surgeons Need To Know: Adjuvant Treatment for Resectable …
    MinuteCE®

    What Dermatologists & Surgeons Need To Know: Adjuvant Treatment for Resectable Stage II Melanoma

    0.75 program credits
  • GPRC5D-Targeted Bispecifics in Relapsed/Refractory Multiple Myeloma: Practical …
    CME/CE

    GPRC5D-Targeted Bispecifics in Relapsed/Refractory Multiple Myeloma: Practical Expert Consensus on a New Target with Unique Adverse Events  

    0.25 credits
  • ACC 2024: What's Really New in Electrophysiology That Will Change My Practice?
    NEW EPISODE
    MinuteCE®

    ACC 2024: What's Really New in Electrophysiology That Will Change My Practice?

    0.50 program credits
  • Experts on Call: Connecting Specialists and PCPs to Improve Patient-Centered Ob…
    CME/CE

    Experts on Call: Connecting Specialists and PCPs to Improve Patient-Centered Obesity Management 

    1.00 credits
  • Key Advances in Heart Health: Insights From the American College of Cardiology …
    MinuteCE®

    Key Advances in Heart Health: Insights From the American College of Cardiology 2024 Scientific Sessions 

    0.50 credits 5 episodes
  • Managing Immunotherapy-Related Adverse Events during Adjuvant Treatment for Res…
    MinuteCE®

    Managing Immunotherapy-Related Adverse Events during Adjuvant Treatment for Resectable Melanoma

    0.75 program credits

Industry Feature

  • Against the Odds: Improving Survival for Children with Pulmonary Vein Stenosis
    Medical Industry Feature

    Against the Odds: Improving Survival for Children with Pulmonary Vein Stenosis

  • Delivering Transformation: Reducing Maternal Mortality Through Systemic Change
    Medical Industry Feature

    Delivering Transformation: Reducing Maternal Mortality Through Systemic Change

  • Severe Asthma: An Exploratory Study on Mucus Plugging
    Medical Industry Feature

    Severe Asthma: An Exploratory Study on Mucus Plugging

  • Treating Wet AMD: A Look at Anatomic Outcomes
    Medical Industry Feature

    Treating Wet AMD: A Look at Anatomic Outcomes

  • Advancing the Science of Anemia Due to CKD
    Medical Industry Feature

    Advancing the Science of Anemia Due to CKD

  • Managing Refractory Cytomegalovirus After Hematopoietic Cell Transplant
    Medical Industry Feature

    Managing Refractory Cytomegalovirus After Hematopoietic Cell Transplant

Schedule8 May 2024